Bristol-Myers Squibb Market Cap 2006-2019 | BMY

Bristol-Myers Squibb market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Bristol-Myers Squibb market cap as of January 23, 2020 is $108.95B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $108.950B $22.561B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.912B 17.11
Roche Holding AG (RHHBY) Switzerland $290.307B 0.00
Merck (MRK) United States $225.472B 17.47
Pfizer (PFE) United States $225.294B 13.39
Novartis AG (NVS) Switzerland $217.538B 18.36
Novo Nordisk (NVO) Denmark $145.845B 25.14
Eli Lilly (LLY) United States $135.580B 25.04
AstraZeneca (AZN) United Kingdom $131.713B 23.79
AbbVie (ABBV) United States $126.099B 9.88
Sanofi (SNY) France $124.205B 15.26
GlaxoSmithKline (GSK) United Kingdom $119.273B 14.45
Bayer (BAYRY) Germany $80.535B 11.93
H Lundbeck (HLUYY) Denmark $8.089B 14.06